The Computational Tumor Immunology Core (CTIC)
The Computational Tumor Immunology Core (CTIC)
批准号:
10505677
负责人:
Derin B Keskin
金额:
$25.99万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-08-31
关键词:
AreaAtlasesAwardCancer PatientCellsClinicalClonal EvolutionCollaborationsDataData AnalysesEpitopesGenomicsHereditary Nonpolyposis Colorectal NeoplasmsImmuneImmunopreventionInterceptLeadLungMalignant NeoplasmsMalignant neoplasm of lungMutationMutation AnalysisNodulePatientsPremalignant NeoplasmProteomicsRNAResearch PersonnelResearch Project GrantsResearch SupportResource SharingRoleScienceServicesThe Cancer Genome AtlasTumor AntigensVaccinesValidationcancer geneticscomputerized toolsexperiencegenomic dataimmunogenicityimprovedinnovationinsertion/deletion mutationneoantigensnew technologynovelprogramssuccesstooltumortumor immunologyvaccine immunogenicityworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CTIC Core: Project Summary/Abstract
The Computational Tumor Immunology Core (CTIC) will provide CAP-IT CRI researchers with state-of-the-art
computational genomic, tumor immunology, immunopeptidomic, and spatial genomic services to support
research projects for immunoprevention of patients with a. Lynch syndrome (LS; Project 1), b. lung cancer non-
solid nodule (NSN), pre-malignant neoplasms (Project 2), and c. any new CAP-IT projects that are subsequently
approved by the CAP-IT program. CTIC investigators include accomplished leaders in computational cancer
genetics, tumor immunology, single-cell profiling, and spatial genomics. We have significant experience with all
proposed analyses to be performed. As the CTIC areas of focus are dynamic and rapidly evolving, we anticipate
incorporating new technologies and computational strategies as they develop to help drive Projects 1 and 2. The
CTIC will successfully delineate LNP RNA immunoprevention and immune interception vaccines for LS and NSN
patients and provide necessary shared resources for the CAP-IT, network-wide.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金